Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervix

• Published in: Cancer Vol. 58; no. 8; pp. 1709 - 1713
• Main Authors: Potish, Roger A., Twiggs, Leo B., Adcock, Leon L., Prem, Konald A., Savage, John E., Leung, Benjamin S.
• Format: Journal Article
• Language: English
• Published: New York Wiley Subscription Services, Inc., A Wiley Company 15.10.1986; Wiley-Liss
• Subjects: Adenocarcinoma - physiopathology; Biological and medical sciences; Carcinoma, Squamous Cell - physiopathology; Female; Female genital diseases; Gynecology. Andrology. Obstetrics; Humans; Lymphatic Metastasis; Medical sciences; Menopause; Prognosis; Receptors, Estrogen - physiology; Receptors, Progesterone - physiology; Tumors; Uterine Cervical Neoplasms - physiopathology; Human; Prognosis; Gynecology; Estrogen; Uterine cervix; Malignant tumor; Cytosol; Female genital diseases; Progestagen; Tumor; Uterine cervix diseases; Biological receptor; Hormonal receptor
• ISSN: 0008-543X; 1097-0142
• DOI: 10.1002/1097-0142(19861015)58:8<1709::AID-CNCR2820580822>3.0.CO;2-B

Tissue levels of cytosolic estrogen receptors (ERc) and progesterone receptors (PRc) have been shown to have prognostic meaning in hormonally responsive cancers arising in the breast and endometrium. Although carcinomas of the uterine cervix rarely respond to hormonal manipulation, the normal cervical stroma and epithelia contain ERc and PRc. To study the prognostic value of these receptors, 65 cervical carcinomas for ERcand PRcwere assayed before initiation of surgical or radiation therapy. In premenopausal women, logistic models demonstrated that clinical stage, surgical stage, and receptor level independently predict survival. If confirmed in further studies, ERc and PRc may prove to be useful prognostic factors in the management of cervical carcinomas.